At the news
? BEARISHIMPACT 5/10 CLUSTER filed Aug 5, 2026 at 16:01 ET
Two insiders at Fate Therapeutics, including the CEO, sold a combined $204K worth of shares in open-market transactions on August 4, 2026. While the dollar amount is modest relative to the $303M market cap, multi-executive selling at a struggling biotech with a weak historical follow-through on our calls warrants caution.
- Two insiders sold a total of 82,747 shares for $204,506 in open-market transactions on Aug 4, 2026.
- President & CEO Bahram Valamehr sold 43,947 shares for $108K; board member Cindy Tahl sold 38,800 shares for $95K.
- This is a cluster of C-suite + board sells, suppressing the typical informational signal of insider sales.
- The total sale value of $204K represents ~0.07% of the $303M market cap, below the 0.1% materiality threshold.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access